LLY

986.64

-1.73%↓

JNJ

228.71

+0.86%↑

ABBV

209.5

-0.44%↓

UNH

389.84

-0.97%↓

AZN

183.98

+1.3%↑

LLY

986.64

-1.73%↓

JNJ

228.71

+0.86%↑

ABBV

209.5

-0.44%↓

UNH

389.84

-0.97%↓

AZN

183.98

+1.3%↑

LLY

986.64

-1.73%↓

JNJ

228.71

+0.86%↑

ABBV

209.5

-0.44%↓

UNH

389.84

-0.97%↓

AZN

183.98

+1.3%↑

LLY

986.64

-1.73%↓

JNJ

228.71

+0.86%↑

ABBV

209.5

-0.44%↓

UNH

389.84

-0.97%↓

AZN

183.98

+1.3%↑

LLY

986.64

-1.73%↓

JNJ

228.71

+0.86%↑

ABBV

209.5

-0.44%↓

UNH

389.84

-0.97%↓

AZN

183.98

+1.3%↑

Search

Quidel Corp

Fechado

10.83 5.04

Visão Geral

Variação de preço das ações

24h

Atual

Mín

10.3

Máximo

10.84

Indicadores-chave

By Trading Economics

Rendimento

39M

-92M

Vendas

-104M

620M

Margem de lucro

-14.811

Funcionários

6,500

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+16.57% upside

Dividendos

By Dow Jones

Próximos Ganhos

4 de ago. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-140M

560M

Abertura anterior

5.79

Fecho anterior

10.83

Quidel Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

18 de mai. de 2026, 23:10 UTC

Ações em Alta

Stocks to Watch: Agilysys, XP

18 de mai. de 2026, 18:44 UTC

Grandes Movimentos do Mercado

Claritev Shares Recover After Comments About DOJ

18 de mai. de 2026, 23:55 UTC

Ganhos

Review & Preview: Earnings' Last Gasp -- Barrons.com

18 de mai. de 2026, 23:47 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

18 de mai. de 2026, 23:47 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for U.S.-Iran Deal -- Market Talk

18 de mai. de 2026, 23:37 UTC

Conversa de Mercado

Gold Rises Amid Hopes for U.S.-Iran Peace Deal -- Market Talk

18 de mai. de 2026, 22:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Lens Technology Ju Teng International Shares to Resume Trading on Hong Kong Exchange on May 19

18 de mai. de 2026, 22:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Lens Technology: Acquisition of Remaining Ju Teng International Shares to Cost HK$1.91B

18 de mai. de 2026, 22:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Lens Technology to Make Offer for Remainder Shares of Ju Teng International Only After Completion of Stake Purchase

18 de mai. de 2026, 22:25 UTC

Aquisições, Fusões, Aquisições de Empresas

Lens Technology to Acquire 333.71M Ju Teng International Shares for HK$2.20 Each

18 de mai. de 2026, 22:24 UTC

Aquisições, Fusões, Aquisições de Empresas

Lens Technology to Acquire 27.81% Stake in Ju Teng International for HK$734.17M

18 de mai. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

18 de mai. de 2026, 20:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Financial Services Roundup: Market Talk

18 de mai. de 2026, 20:25 UTC

Ganhos

Correct: XP 1Q Total Client Assets BRL1.53T

18 de mai. de 2026, 20:23 UTC

Ganhos

XP 1Q Total Client Assets BRL1.53B

18 de mai. de 2026, 20:19 UTC

Ganhos

XP 1Q Adj EPS BRL2.49 >XP

18 de mai. de 2026, 20:19 UTC

Ganhos

XP 1Q Rev BRL4.73B >XP

18 de mai. de 2026, 19:10 UTC

Conversa de Mercado

Oil Presses Higher With No Hormuz Reopening in Sight -- Market Talk

18 de mai. de 2026, 19:00 UTC

Ganhos

5 Stocks with 5% Yields and Market-Beating Returns -- Barrons.com

18 de mai. de 2026, 18:52 UTC

Conversa de Mercado

U.S. Natural Gas Futures Gain As Weather Heats Up -- Market Talk

18 de mai. de 2026, 18:17 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

NextEra's Dominion Acquisition Unlikely to Spur Wider Utility Consolidation -- Market Talk

18 de mai. de 2026, 17:22 UTC

Conversa de Mercado

Tokenized Assets Expected to be Over $1T By 2030 -- Market Talk

18 de mai. de 2026, 16:57 UTC

Aquisições, Fusões, Aquisições de Empresas

The Long Regulatory Road Ahead for the NextEra-Dominion Deal -- Barrons.com

18 de mai. de 2026, 16:57 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

18 de mai. de 2026, 16:57 UTC

Conversa de Mercado

Commodities Higher as Traders Want Physical Assets -- Market Talk

18 de mai. de 2026, 16:54 UTC

Aquisições, Fusões, Aquisições de Empresas

Vinci Doesn't Set Out Financial Details of Deal

18 de mai. de 2026, 16:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Vinci: Acquisition of New Brunswick-Based Group Stregthens Presence in Eastern Canada

18 de mai. de 2026, 16:49 UTC

Aquisições, Fusões, Aquisições de Empresas

Vinci: Modern Group is Roadwork, Civil Engineering Specialist

18 de mai. de 2026, 16:49 UTC

Aquisições, Fusões, Aquisições de Empresas

Vinci: Modern Group Made Revenue of Around 50 Mln Euros Last Year

18 de mai. de 2026, 16:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Vinci Buys Canada's Modern Group of Companies

Comparação entre Pares

Variação de preço

Quidel Corp Previsão

Preço-alvo

By TipRanks

16.57% parte superior

Previsão para 12 meses

Média 12.03 USD  16.57%

Máximo 13 USD

Mínimo 11 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Quidel Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

6 ratings

1

Comprar

4

Manter

1

Vender

Informação Financeira

Custos administrativos e de venda

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

Resultado Operacional

$

Sobre Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat